CoChat

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years

Wallymahmed, M. E., Foy, P., Shaw, D., Hutcheon, R., Edwards, R. H. T., MacFarlane, I. A. · 1997 · Clinical Endocrinology
Cited by 115

The DOI matches its Crossref record.

Abstract

OBJECTIVE: Adults with GH deficiency complain frequently of low energy levels, emotional lability and mental fatigue resulting in a low perceived quality of life (QOL). Body composition is altered with increased fat mass and decreased lean body mass and muscle strength is reduced. The aims of this study were to determine the effects of replacement GH treatment on: (a) body composition and muscle strength and (b) QOL, using specifically selected and adapted measures. DESIGN: A 12‐month study (double‐blind placebo‐controlled for the first 6 months and open for the second 6 months) of GH replacement injections (0.125 iu/kg/week for the first month and 0.25 iu/kg/week for the following 5 months of each study period) in GH deficient adults on QOL, body composition and muscle strength. This was followed by an open study of a further 12 months' GH treatment assessing QOL and muscle strength. Finally, QOL was assessed after up to 3 years of GH replacement treatment. PATIENTS: Thirty of the 32 adult patients with GH deficiency enrolled completed the initial 12‐month study (10 male, mean age 33.5 years, mean (SD) stimulated serum GH response 3.0 mU/l (2.86)). Nineteen patients then opted to continue GH treatment. Of these, 13 patients were available for assessment after a further 12 months' and 24 months' treatment. MEASUREMENTS: Health‐related QOL was assessed using 2 specifically adapted scales for adults with GH deficiency: the Life Fulfilment Scale and the Impact Scale. In addition 4 other self‐rating questionnaires were used: Nottingham Health Profile, Hospital Anxiety and Depression Scale, Self Esteem Scale and Mental Fatigue Scale. Body composition was assessed by DEXA and quadriceps muscle strength by measuring maximum voluntary contractions. RESULTS: In the initial 12 months' placebo‐controlled study perceived energy levels increased after 6 and 12 months of GH treatment (P<0.01 compared with baseline) in the patients receiving GH for the full 12‐month period. There were no changes in energy levels throughout the study in the group receiving placebo for the first 6 months. Also small improvements in impact scores were found after 6 months of GH treatment (P<0.05) but this was not sustained at 12 months. In both GH and placebo groups life fulfilment worsened after 6 months, but then improved to baseline values after 12 months. In the patients who persisted with GH replacement, energy levels continued to improve (at 2 years, P<0.01 compared with baseline) but then fell (at 3 years, P = NS compared with baseline). A similar pattern was observed in emotional reaction scores. However, improvements in self‐esteem were maintained (at 3 years, P<0.05 compared with baseline). Body composition altered favourably over the initial 12‐month study period with a significant increase in lean mass and decrease in fat mass in both groups after 6–12 months of GH. There were no changes in muscle strength in either group during the initial 12‐month study. However, in the patients who were available for assessment after a further 12 months of GH treatment, muscle strength increased significantly (P<0.02 compared with baseline). CONCLUSION: GH replacement treatment for 6–12 months leads to significant improvements in body composition (DEXA) but longer‐term treatment may be needed to increase muscle strength. Self‐esteem scores improve and are maintained after 3 years of treatment. Energy levels and emotional reaction improve during treatment for up to 2 years but decline thereafter.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1997.2801076.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 115

Metadata

Authors
Wallymahmed, M. E., Foy, P., Shaw, D., Hutcheon, R., Edwards, R. H. T., & MacFarlane, I. A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1997-10
Volume
47
Issue
4
Pages
439-446
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2024858582
Cited by
115
References
0
FWCI
3.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. https://app.cochat.ai/papers/10.1046/j.1365-2265.1997.2801076.x
The paper
Wallymahmed, M. E., Foy, P., Shaw, D., Hutcheon, R., Edwards, R. H. T., & MacFarlane, I. A. (1997). Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1997.2801076.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.